Patent · US Active

Compositions and methods for treatment of filovirus-mediated diseases

US8475804B2 · kind B2 · utility

11Cited by

0References

4Claims

0Family size

Assignees

U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND · US
Zalicus, Inc. · US

Inventors

Lisa M. Johansen · Belmont, US
Joseph Lehar · Lexington, US
Benjamin G. Hoffstrom · Seattle, US
Gene G. Olinger · Frederick, US
Andrea R. Stossel · Thurmont, US

Key dates

Filing date	Feb 22, 2010
Grant date	Jul 2, 2013
Priority date	—
Expiry date	May 4, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.